This was accompanied by a 5.2 mmHg reduction in systolic blood pressure
Diabetes Care 38 , 11451153 (2015)
There also isnt a way to know if these posts come from people currently taking GLP-1s, how long theyve taken them, other coexisting conditions, or even other medications they are taking that could be causing these side effects, he says
A September 2023 study found that semaglutide, the main ingredient in Ozempic, outperformed Vyvanse and topiramate, both common treatments for severe binge eating disorder
While overall food intake may be lower on this medication, nutrient intake is even more important to consider
Semaglutide (Ozempic/Wegovy): a GLP-1 receptor agonist that reduces appetite and slows gastric emptying, which is part of why weight loss can be substantial